Next Article in Journal
Mechanism of Sphingosine 1-Phosphate- and Lysophosphatidic Acid-Induced Up-Regulation of Adhesion Molecules and Eosinophil Chemoattractant in Nerve Cells
Next Article in Special Issue
Recombinant Cytokines from Plants
Previous Article in Journal
Novel Strategies for Drug Discovery Based on Intrinsically Disordered Proteins (IDPs)
Previous Article in Special Issue
Membrane-Based Inverse Transition Cycling: An Improved Means for Purifying Plant-Derived Recombinant Protein-Elastin-Like Polypeptide Fusions
Article Menu

Export Article

Open AccessReview
Int. J. Mol. Sci. 2011, 12(5), 3220-3236;

Evolution of Plant-Made Pharmaceuticals

School of Biological Sciences, Monash University, Clayton, Victoria 3800, Australia
Author to whom correspondence should be addressed.
Received: 1 April 2011 / Revised: 5 May 2011 / Accepted: 9 May 2011 / Published: 17 May 2011
(This article belongs to the Special Issue Plant-Derived Pharmaceuticals by Molecular Farming)
Full-Text   |   PDF [204 KB, uploaded 19 June 2014]


The science and policy of pharmaceuticals produced and/or delivered by plants has evolved over the past twenty-one years from a backyard remedy to regulated, purified products. After seemingly frozen at Phase I human clinical trials with six orally delivered plant-made vaccines not progressing past this stage over seven years, plant-made pharmaceuticals have made a breakthrough with several purified plant-based products advancing to Phase II trials and beyond. Though fraught with the usual difficulties of pharmaceutical development, pharmaceuticals made by plants have achieved pertinent milestones albeit slowly compared to other pharmaceutical production systems and are now at the cusp of reaching the consumer. Though the current economic climate begs for cautious investment as opposed to trail blazing, it is perhaps a good time to look to the future of plant-made pharmaceutical technology to assist in planning for future developments in order not to slow this technology’s momentum. To encourage continued progress, we highlight the advances made so far by this technology, particularly the change in paradigms, comparing developmental timelines, and summarizing the current status and future possibilities of plant-made pharmaceuticals. View Full-Text
Keywords: plant-made; recombinant protein; expression system plant-made; recombinant protein; expression system plant-made; recombinant protein; expression system plant-made; recombinant protein; expression system
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Thomas, D.R.; Penney, C.A.; Majumder, A.; Walmsley, A.M. Evolution of Plant-Made Pharmaceuticals. Int. J. Mol. Sci. 2011, 12, 3220-3236.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top